Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)

Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)

The purpose of this research study is to (1) provide access to fenfluramine for patients with intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety of fenfluramine.

The purpose of this research study is to (1) provide access to fenfluramine for patients with intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety of fenfluramine.

Inclusion Criteria:

• Genetic diagnosis of Dravet syndrome with intractable seizures despite failing all available medications for seizures.